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CHAPTER I 
  
INTRODUCTION 
 
Overview 
Blood flow inflicts on the vascular endothelial surface a frictional force per unit area 
known as hemodynamic shear stress and the transcriptional response of endothelial cells 
exposed to non-laminar flow with low shear stress similar to atherosclerosis prone areas 
is distinct from that elicited by atheroprotective laminar flow with high shear stress. 
However, the critical mediators of endothelial cell mechanotransduction involved in 
atherosclerosis have not been clearly delineated. Tie1 is an orphan receptor tyrosine 
kinase expressed almost exclusively in endothelial cells and there is recent evidence to 
suggest that its expression is regulated by atherogenic shear stress making it a possible 
component of the endothelial mechanotransduction machinery.  However, ablation of 
Tie1 expression results in embryonic lethality, thus defining a role for Tie1 signaling in 
atherosclerosis has been elusive. We therefore hypothesized that Tie1 plays an essential 
role in endothelial response to atherogenic shear. 
The primary focus of my research has been to map the expression profile of Tie1 in 
adult macrovasculature, evaluate the effect of Tie1 receptor attenuation on atherosclerosis 
progression in vivo and delineate this effect on shear stress-modulated endothelial cell 
biology in vitro. Chapter I will describe the genetic and structural aspects of Tie1 and its 
role in early embryonic development. It will also summarize the roles that Tie1 plays in 
in vitro endothelial cell biology. Chapter I will go on to provide pertinent background 
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information on fluid dynamics and the different models of shear stress 
mechanotransduction in vitro. The effect of shear stress on tissue responses and 
subcellular activity will also be discussed. Finally, Chapter I will evaluate the role of 
shear stress in atherogenesis and the tripartite argument involving Tie1, shear stress and 
atherosclerosis will be presented. Chapter II will define the expression of Tie1 in vivo and 
compare Tie1 promoter activity in the aortas of immature 4 week-old mice to those of 12 
week-old adult littermates in atherosclerosis-prone and atherosclerosis-resistant regions 
of the vasculature. Also, Chapter II will demonstrate the use of a unique, in vivo shear 
stress modifying cast to evaluate the effect of different flow profiles and shear stress 
magnitudes on Tie1 promoter activity. Next, Chapter III focuses on the effect of Tie1 
genetic dose reduction on atherosclerosis progression. It also demonstrates the 
differences in atherosclerosis burden between regions of the aorta that are distinguished 
in part by their local shear stress profiles. In Chapter IV, a novel method of isolating 
murine aortic endothelial cells will be presented using a transgenic mouse model that 
allows for conditional inactivation of Tie1. It will detail the methodology used and 
discuss the benefits of this in vitro model. Chapter V will report assessments of shear 
stress-induced alterations in Tie1 expression. It will evaluate the effect of in vitro Tie1 
deletion on flow-mediated endothelial responses. Last, in Chapter VI I conclude by 
discussing the significance of Tie1 in a shear stress-regulated environment, specifically in 
the context of atherosclerosis, and I will highlight future experiments to explore the 
effects of biomechanical forces on the role of Tie1 in endothelial biology. 
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The Tie1 Receptor Tyrosine Kinase 
The Tie (Tyrosine kinase with Ig and EGF homology) family of receptor tyrosine 
kinases, comprising of Tie1 and Tie2, was first reported in 1992 (Partanen et al., 1992). 
To date, studies have shown that Tie1 is almost exclusively expressed only in endothelial 
cells and cells of hematopoietic lineage (Partanen et al., 1992; Shahrara et al., 2002; Puri 
& Bernstein, 2003; Antonescu et al., 2009). Although the sister receptors share a high 
degree of structural homology, the subsequent discovery of angiopoietins (Ang), specific 
ligands for Tie2 but not for Tie1 has thwarted efforts to elucidate its function. However, 
in vivo gene disruption studies have provided some insight into the role of Tie1 during 
development. While investigators speculate that Tie1 may serve only to modulate Tie2 
signaling, recent evidence suggests a Tie2 independent role for Tie1.  
 
The Role of Tie1 in Development  
Tie1 is an orphan receptor tyrosine kinase that is expressed almost exclusively in 
endothelial cells (Partanen et al., 1992). It is the last receptor tyrosine kinase expressed 
during embryonic vascular development and ablation of Tie1 expression results in 
embryonic lethality after embryonic day 13.5 due to severe edema, hemorrhages and loss 
of microvessel integrity (Figure 1.1.1) (Puri et al., 1995; Sato et al., 1995; Qu et al., 
2010). Puri et al (Puri et al., 1995) and Sato et al (Sato et al., 1995) both showed that at 
e13.0, Tie1-/- embryos have a normal vascular network suggesting that Tie1 is not 
essential for vasculogenesis. Interestingly, studies using chimeric embryos (mixed Tie1 
null and wildtype cells) revealed reduced representation of Tie1 null endothelial cells in 
the vasculature of mature organs due either to increased cell death, reduced survival or  
 4 
 
Figure 1.1.1 Loss of Tie1 leads to early embryonic lethality.  (A) Attenuation of Tie1 
expression causes edema and massive hemorrhage at e13.5 and early embryonic death by 
e16.5. (B) Insertion of neomycin selection cassettes (neo/neo) significantly reduces Tie1 
expression. Figure modified from Qu (2009). 
A 
B
A 
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replacement by competitive proliferation of normal endothelial cells, supporting a role for 
Tie1 in endothelial cell survival (Partanen et al., 1996).  
Tie1-/- embryos display increased vascular density and hyperactive endothelial cells 
(Patan, 1998). These Tie1 knockout cells have increased intra- and trans-cellular vacuoles 
suggesting a requirement for Tie1 in inhibiting endothelial cell stretching and allowing 
cell maturation (Figure 1.1.2). Additionally, Tie2 is expressed before Tie1 and its 
activation enhances endothelial cell activation, hence leading some investigators to 
postulate that Tie1 may function to counteract Tie2, and loss of inhibition by Tie1 
prevents maturation of endothelial cells (Patan, 1998). Taken together, these results 
suggest that Tie1 is not required for vasculogenesis, but it is required during embryonic 
development for the integrity and survival of vascular endothelial cells.  
 
The Expression Profile of Tie1 
 Tie1 expression is driven by an octamer element (5’-ATGCAAAT-3’) similar to Tie2 
(Figure 1.1.3) (Boutet et al., 2001). Boutet et al showed that mutations in the element 
decreased Tie1 promoter activity indicating that the promoter functions as a positive 
regulator. Further, they showed that the promoter binds the ubiquitous transcription factor 
Oct1 and an unidentified co-factor that was not found in control non-endothelial cells. 
Identification of this promoter element and insertion of a LacZ reporter has facilitated 
investigations in Tie1 expression.  
Tie1 expression varies in different organs pre- and post-natally (Taichman et al., 
2002). Taichman et al found Tie1 is expressed in the heart, kidneys, liver, lungs and brain 
between embryonic day 13.5 and birth (Figure 1.1.4). At 6 weeks after birth, Tie1  
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Figure 1.1.2 Ultrastructure of Tie1-/- endothelial cells in the capillaries of embryonic 
small intestine mucosa. (A, B) Capillaries from Tie1-/- embryo showing “active” 
endothelial cells lining the lumen. Cellular extensions and filopodia invade the lumen 
(arrowheads), and endothelial cells show numerous intracellular and transcellular holes 
(arrows). (C) Endothelial cells from wild-type embryo have less extensions. Adapted 
from Patan (1998). 
 
Endothelial cell, en; epithelial cell, ep; vessel lumen, lu; periendothelial cell, pe. 
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Figure 1.1.3 Tie1 and Tie2 promoter sequences. Illustration of murine Tie1 and Tie2 
promoters. The consensus octamer element (bolded and underlined) of Tie1, 5’-
ATGCAAAT-3’, and Tie2 are located at -312 bp and -669 bp respectively. Black boxes 
indicate the promoter sequence position; arrows indicate transcription start site and the 
first exon of the gene is represented by a grey box. Modified from Boutet (2001). 
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embryonic day 14.5 [11, 12]. The most striking increase in Tie1 expression
occurred in the late gestational (embryonic day 18.5) and newborn periods,
where Tie1 mRNA was approximately 10 and 20 times higher than that
detected at embryonic day 11.5. Again, this ‘‘burst’’ of Tie1 expression in
the developing lung is coincident with the period of death from pulmonary
congestion and hemorrhage observed among Tie1-null mutant embryos sur-
viving to birth [12].
In contrast, this surge in mRNA expression was not seen in parallel stu-
dies of other vascular receptor tyrosine kinases (Figure 2). Specifically, Tie2
mRNA demonstrated a gradual and progressive increase in expression with
lung development, specifically lacking the punctuated increase in later
embryonic and newborn lung observed for Tie1. The lack of simultaneous
change in Tie2 suggests that augmented Tie1 expression is not coincident
with an activation of angiopoietin signaling. In addition, another endothelial-
specific RTK, the vascular endothelial growth factor (VEGF) receptor flk1/
VEGFR2 [17] demonstrated a gradual increase in expression more similar to
FIGURE 1 A unique pattern of Tie1 promoter activity in the developing lung. Tie1 promoter activity was
determined in the organs of recombinant mice expressing the lacZ reporter gene under the regulatory
domains of Tie1. Heterozygous mice develop normally [11]. Protein was extracted from each organ at
sequential embryonic and postnatal developmental stages, and b-gal activity measured by chemilumines-
cence as an indicator of lacZ (and thus Tie1 promoter) activity. Whereas stable Tie1 promoter activity was
observed in each heart, kidney, liver, and brain, a significant increase in Tie1 promoter activity is seen in
the adult lung. Data shown are the mean ! standard deviations of organ-specific expression in 4 animals.
b-Gal activity for each organ is normalized to the total protein concentration.
Tie1 in Lung Development 117
 
 
 
Figure 1.1.4 Comparison of Ti 1 romoter activi y pre and postnatal mice. Tie1 
promoter activity was determined in the organs of mice expressing the lacZ reporter gene 
under the regulatory domains of Tie1. Whereas the heart showed stable expression, and 
expression declined in the kidney, liver an  brain after 6 weeks, Tie1 promoter activity 
signific ntly increased in the adult lungs. Adapted from Taichman (2003). 
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expression in the heart remains the same, but expression in the kidneys, liver and brain is 
almost eliminated. Interestingly, lung expression of Tie1 increased up to 4-fold consistent 
with a role of Tie1 in formation and maturity of the pulmonary vascular bed. Hence, Tie1 
transcriptional activity is increased during stages of developmental angiogenesis and the 
heterogeneity of Tie1 expression in different organs suggests a context dependent role for 
this receptor in endothelial function. 
Tie1 expression is not just increased in adult normal physiology but also in 
pathological angiogenesis (Korhonen et al., 1992; Kaipainen et al., 1994). Tie1 is 
expressed in endothelial cells that re-populate the denuded surface of carotid arteries 
(Fujikawa et al., 1999). Immunohistochemical analyses of balloon-injured rat carotid 
arteries found increased Tie1 along with Tie2 expression in recently re-endothelialized 
carotid arteries. Fujikawa et al also showed that the intensity of Tie1 expression increased 
during the later post-injury time points, correlating with an increase in the density of 
endothelial cells. They further confirmed this in vitro, showing maximal Tie1 expression 
in human umbilical vein endothelial cells only when they reach 100% confluency. This 
study suggests that expression of Tie1 correlates with expansion of the endothelial cell 
population induced by vascular injury.  
 Interestingly, expression of Tie1 is increased in a number of tumors and its expression 
has been found to correlate inversely with survival of gastric cancer patients (Lin et al., 
1999). Immunocytochemistry analyses has revealed that Tie1 is expressed in epithelial 
tumor cells in breast (Cance et al., 1993; Tseng et al., 2001; Yang et al., 2003; Uruno et 
al., 2004), colon (Yang et al., 2003), gastric (Lin et al., 1999) and thyroid (Ito et al., 
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2004) cancers. Importantly, the addition of Ang1 to breast and colon epithelial tumor 
cells phosphorylated Tie1 (Rees et al., 2007). 
 In the vasculature, besides endothelial cells, Tie1 is also expressed in platelets 
(Tsiamis et al., 2000). Platelet Tie1, however, is different from endothelial Tie1, western 
blot analyses showed that the platelet form to be 110kDa in contrast to the endothelial 
form at 135/125 kDa doublet. Unlike the endothelial form of Tie1, the platelet form of 
Tie1 cannot be cleaved by phorbol ester, suggesting to the investigators that one of its 
functions may be to competitively bind any yet unidentified Tie1 ligands (Tsiamis et al., 
2000). 
 
Structure of the Tie Family Receptors 
The extracellular portion of the Tie receptors consists of multiple domains and as 
described by Macdonald et al, the extracellular fragment of Tie1 folds into a “globular 
head and a short rod-like stalk” (Macdonald et al., 2006). The “globular head” consists of 
three immunoglobulin (Ig)-like domains separated by three epidermal growth factor 
(EGF)-like repeats (Figure 1.1.5) (Macdonald et al., 2006). The stalk domain has been 
suggested to function as a “spacer” between the ligand binding site and the cell 
membrane and consists of three β-sheet fibronectin (FN) type III repeats (Partanen et al., 
1992). This specific combination and sequence of domains is unique to the Tie family of 
receptors (Sato et al., 1993). The cytoplasmic portion is comprised of two tyrosine kinase 
domains that are highly conserved between Tie1 and Tie2. Although earlier studies 
reported 2 Ig repeats in the extracellular domain (Figure 1.1.5A) (Partanen et al., 1992), 
Macdonald et al recently confirmed the presence of a third Ig repeat, further bridging the  
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Figure 1.1.5 Model of Tie1 and Tie2 structures. (A) Early prediction of Tie1 and Tie2 
structure with domain homology comparisons. (B) Updated model of Tie1 structure. Tie 
receptors comprise of intracellular kinase domain, the extracellular fragment consists of 3 
fibronectin type III repeats, and 3 Ig-like domains separated by 3 EGF-like repeats.  
These receptors dimerize and contact at the intracellular kinase domains. No interaction 
in the extracellular domains has been reported. Adapted from Sato (1993) and 
MacDonald (2006). 
 
Immunoglobulin-like, Ig; epidermal growth factor, EGF; Fibronectin Type III, FNIII; 
transmembrane, TM; Tyrosine Kinase domain, TKI and TKII. 
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similarity of Tie1 to Tie2 (Macdonald et al., 2006). In fact, Macdonald et al postulated 
that the kinase domain and not the Fc fragment is responsible for the heterodimerization 
of Tie1 with Tie2. 
Although the intracellular domains of Tie1 and Tie2 share an overall amino acid 
identity of approximately 80%, the extracellular domains are more divergent, with an 
amino acid identity of less than 40% (Dumont et al., 1992; Partanen et al., 1992; Sato et 
al., 1993). In the extracellular region, the highest identity conservation between the two 
receptors is found at the EGF repeats, an area that is critical for ligand binding 
(Macdonald et al., 2006), providing a potential explanation for the selectivity of 
angiopoietin binding to Tie2 but not Tie1. 
 
Mechanism of Tie1 Signaling 
Despite a high degree of homology with Tie2 and extensive efforts, a ligand for Tie1 
still has not been found.  Hence, the function of the Tie1 orphan receptor remains 
enigmatic. 
 
Tie1 is Capable of Signaling in the absence of Tie2 
Although Tie1 can be activated upon stimulation with Ang1 and Ang2, no direct 
receptor-ligand interaction has been found (Davis et al., 1996; Maisonpierre et al., 1997; 
Valenzuela et al., 1999). Since a specific ligand for Tie1 has not been found, two studies 
utilized a chimeric receptor approach to investigate the signaling mechanism and function 
of this orphan receptor. Marron et al fused the ectodomain of the TrkA to the 
transmembrane and intracellular domains of Tie1. However, the addition of the TrkA 
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ligand, neurotrophin growth factor (NGF), did not elicit phosphorylation of the Tie1 
endodomain (Marron et al., 2000). Although chimeric Tie1 receptor experiments did not 
demonstrate Tie1 autophosphorylation (Marron et al., 2000), evidence of its association 
with SH2 domain containing tyrosine phosphatase 2 (Shp2) (Marron et al., 2000) 
suggests that the phosphorylated Tie1 state may be transient. 
In a similar study, Kontos and colleagues used a cell line stably expressing csf-Tie1 
(colony stimulating factor receptor-Tie1) chimeric receptor, which allowed ligand 
activation with colony-stimulating factor 1 (Kontos et al., 2002). They showed that the 
kinase domain is active and causes Tie1 auto-phosphorylation. Notably, they also found 
that the Tie1 endodomain associates with the p85 subunit of phosphatidylinositol 3-
kinase (PI3K) in vitro. Moreover, Kontos et al demonstrated that in the absence of Tie2, 
Tie1 auto-phosphorylation in vitro increased production of 3-phosphoinositides and 
subsequent phosphorylation of Akt by PI3K. This study provided evidence that Tie1 is 
capable of signaling and that Tie1 may share a common signaling pathway with Tie2. 
 
Proteolytic Cleavage of Tie1  
Several cell surface receptors such as the epidermal growth factor receptor (EGFR) 
and the platelet derived growth factor receptor (PDGFR) undergo cleavage to modulate 
their mechanism of action (Prenzel et al., 1999; Nemoto et al., 2005). While release of 
the ectodomain may be required to halt ligand stimulated signaling, the extracellular 
domain of some receptor tyrosine kinases suppress the signaling capabilities of their 
intracellular domains (Vecchi et al., 1996). Furthermore, endodomain expression of 
similar receptor tyrosine kinases results in ligand independent activation of their 
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signaling activity (Chantry, 1995). Tie1 is also subject to extracellular proteolytic 
cleavage in the presence of either protein kinase C (PKC) (Yabkowitz et al., 1997), 
vascular endothelial growth factor (VEGF) (Tsiamis et al., 2002), phorbol 12-myristate 
13 acetate (PMA) (Marron et al., 2000) or tumor necrosis factor-α (TNF-α) (Yabkowitz 
et al., 1999) generating a membrane bound receptor fragment comprising the intracellular 
and transmembrane domains. Marron et al showed that the truncated Tie1 product 
persists in the cytosol for several hours (Marron et al., 2000), after which a γ-secretase 
mediated cleavage of the endodomain from the membrane initiates the lysosomal 
degradation of the internalized fragment (Marron et al., 2007). The cleaved Tie1 product 
was also found associated with tyrosine phosphorylated proteins, such as the tyrosine 
phosphatase and adaptor protein Shp2 (Marron et al., 2000). Hence, the prolonged 
existence of the cleaved Tie1 intracellular fragment in the cytosol and its association with 
secondary messengers suggest that this Tie1 endodomain may have further intracellular 
signaling functions (Marron et al., 2000). 
Truncation of Tie1 by VEGF may require tyrosine phosphorylation of the receptor 
(Tsiamis et al., 2002). Singh et al showed that this truncated Tie1 was tyrosine 
phosphorylated (Singh et al., 2009). Tsiamis et al showed that, addition of the tyrosine 
kinase inhibitor genistein, blocked VEGF induced Tie1 cleavage but use of the tyrosine 
phosphatase inhibitor pervanadate, had no effect. A metalloprotease inhibitor also 
blocked VEGF induced Tie1 cleavage. Hence, VEGF induced cleavage of Tie1 involves 
a tyrosine kinase regulated and metalloprotease mediated process. 
PMA induced cleavage of Tie1 also causes tyrosine phosphorylation of the truncated 
endodomain (Marron et al., 2007). While truncation and tyrosine phosphorylation of Tie1 
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by VEGF was shown to be Tie2 independent (Singh et al., 2009), loss of Tie2 inhibited 
Tie1 tyrosine phosphorylation. Furthermore, addition of PMA enhanced Ang1 induced 
Tie1 phosphorylation, suggesting that Tie2 is involved in tyrosine phosphorylation of 
cleaved Tie1.  
 
Tie1 Associates with Tie2 
Tie1 is commonly found associated with Tie2 (Marron et al., 2000; Saharinen et al., 
2005; Yuan et al., 2007). Saharinen et al reported that stimulation with Ang1 induces 
Tie2 translocation to endothelial cell-cell contacts, and when Tie1 is co-expressed, it also 
translocates to the cell borders. Although Tie1 is found in heterocomplexes with Tie2 in 
human umbilical vein endothelial cells (HUVECs) (Marron et al., 2000; Kim et al., 
2006), in endothelial progenitor cells (EPCs), the receptors were not bound to each other 
(Kim et al., 2006). Hence, in vitro Tie1 is bound to Tie2, and the regulation of Tie2 
signaling by Tie1 may be context dependent. 
Association of Tie1 with Tie2 may modulate Tie2 signaling. Kim et al demonstrated 
that association of cell surface Tie1 with Tie2 inhibited angiopoietin (Ang)-2 mediated 
Tie2 activation (Kim et al., 2006). Another study also reported that the proteolytic 
processing of Tie1 reduces the accumulation of phosphorylated Tie1 at the cell surface 
and enhances the responsiveness of Tie2 to Ang1 induced activation (Marron et al., 
2007). Interestingly, both Tie1 holoreceptor and endodomain bind with Tie2 (Marron et 
al., 2000; Tsiamis et al., 2002). These studies together suggest that either the Tie1 
holoreceptor or endodomain may play a role in regulating ligand activated Tie2 signaling 
through the formation of heterodimeric complexes.  
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Angiopoietin activation of Tie1 requires Tie2 
In support of ligand activated Tie1 signaling, Saharinen et al demonstrated that Tie1 
can be activated by an Ang1 chimeric protein (COMP-Ang1), as well as native Ang1 and 
Ang4, but not by Ang2 or Ang3 (Saharinen et al., 2005). In this study, COMP-Ang1 was 
able to induce tyrosine phosphorylation of Tie1 within 5 minutes and achieving 
maximum activation at 1 hour. These experiments were performed in immortalized 
HUVECs overexpressing Tie1 and the level of Tie1 phosphorylation was very low as 
compared to Ang induced Tie2 phosphorylation. Notably, co-expression with Tie2 was 
required for robust Tie1 activation (Saharinen et al., 2005; Yuan et al., 2007). In the 
absence of Tie2, however, COMP-Ang1 induced Tie1 phosphorylation was significantly 
reduced (Marron et al., 2007). Additionally, Yuan et al showed that a kinase-dead Tie1 
mutant was phosphorylated by Ang1 only in the presence of Tie2 and Ang1 failed to 
activate Tie1 when co-expressed with a kinase-defective Tie2, suggesting a requisite role 
for Tie2 in Ang1 induced Tie1 activation (Yuan et al., 2007).  
 
Tie1 Function In vitro 
 
Tie1 Inhibits Apoptosis in the Absence of Tie2 
On the other hand, using a chimeric receptor approach in vitro, Kontos et al 
demonstrated that in the absence of Tie2, activation of Tie1 induced PI3K mediated Akt 
phosphorylation, reducing UV-irradiation activated caspase-3, and consequently inhibited 
apoptosis (Kontos et al., 2002). The inconsistency of these results to the work of Yuan et 
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al (Yuan et al., 2007) may be due to the different cell systems used, while Kontos et al 
overexpressed the Tie1 chimeric receptor in NIH3T3 cells, Yuan et al assessed 
endogenous receptor expression in HUVECs. Taken together these studies suggest that in 
the absence of Tie2, phosphorylation of Tie1 activates a similar PI3K mediated pathway, 
as does Tie2. This Tie1 signal transduction pathway leads to Akt phosphorylation and 
reduction of cleaved caspase-3 levels, and results in an anti-apoptotic effect not unlike 
Ang1/Tie2 signaling.  
 
Tie1 modulates Tie2 Activity 
 Studies show that cleavage of Tie1 modulates Ang induced Tie2 signaling. VEGF 
induced phosphorylation of Tie2, and VEGF enhancement of Ang1 induced Tie2 
activation, both required association of phosphorylated Tie1 endodomain with Tie2 
(Singh et al., 2009). Marron et al also showed that cleavage of Tie1 augmented Ang1 
induced Tie2 phosphorylation (Marron et al., 2007). Thus regulated processing of Tie1 
regulates Tie2 activity. 
A potential effect of Tie2 modulation by Tie1 is the inhibition of Ang1 induced pro-
survival signaling. Yuan et al found that loss of Tie1 in vivo led to increases in capillary 
density due to increased endothelial cell numbers (Yuan et al., 2007). They affirmed this 
finding in vitro by downregulating Tie1 in HUVECs, and showing potentiated levels of 
phospho-Akt and mitogen activated protein kinases (MAPK).  Thus, either 
downregulation of Tie1 (Marron et al., 2007; Yuan et al., 2007) or shedding of the Tie1 
ectodomain (Marron et al., 2007) augments Ang1 induced Tie2 phosphorylation. This 
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study suggests that Tie1 may prevent endothelial cell survival by inhibiting Ang1 induced 
Tie2 signaling.  
 
Tie1 Promotes Endothelial Cell Activation 
Ang1 induced Tie2 activation promotes endothelial integrity and inhibits apoptosis 
(Kwak et al., 1999; Papapetropoulos et al., 2000; Harfouche et al., 2002). Hence, Tie1 
may activate endothelial cells by inhibiting the ability of Tie2 in maintaining endothelial 
quiescence. Recent studies have indicated an expression of Tie1 in inflammatory tissue of 
rheumatoid arthritis and osteoarthritis patients (Shahrara et al., 2002). Overexpression of 
Tie1 in HUVECs augments inflammatory markers vascular cell adhesion molecule-1 
(VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and endothelial (E)-selectin 
potentially via a p85 mediated pathway (Chan et al., 2008). Conversely, analyses of Tie1 
siRNA transfected HUVECs revealed decrease in inflammatory markers such as ICAM-
1, VCAM-1, E-selectin, toll-like receptor 2 (TLR2), interleukin-1β (IL-1β) but had no 
effect on Tie-2, eNOS or transforming growth factor-β (TGF-β) expression (Chan & 
Sukhatme, 2009). Therefore, Tie1 may play a role in endothelial cell activation and 
promote inflammation. 
 
Summary: Divergent Roles for Tie1 
In summary, the Tie family of tyrosine kinase receptors is critical to maintenance of 
vessel integrity. Although both Tie1 and Tie2 share great homology in the intracellular 
regions, their extracellular domains are vastly different, hence the Tie2 specific ligand, 
angiopoietin has not been found bound to Tie1. Despite the absence of a Tie1 specific 
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ligand, efforts to elucidate the Tie1 signaling mechanism has yielded different results, 
largely due to the co-expression of Tie2 (Figure 1.1.6). Phosphorylation and activation of 
Tie1 by native or synthetic angiopoietins can be achieved, but only with co-expression of 
Tie2. It appears that in the presence of Tie2, Tie1 functions to attenuate the effect of its 
downstream signaling, that is, reducing pro-survival and anti-apoptotic signaling. 
However, in the absence of Tie2, studies suggest that Tie1 assumes the role of Tie2 with 
a resultant effect of inhibiting apoptosis, an effect opposite to that seen when Tie2 is co-
expressed. Hence, in further studies with overexpression of Tie1 and in the presence of 
Tie2, Tie1 appears to have a pro-inflammatory effect, potentially via excessive inhibition 
of Tie2. Conversely, downregulation of Tie1 by siRNA showed a distinct reduction of 
pro-inflammatory molecules potentially due to unfettered Tie2 signaling. While Tie1 is 
predominantly expressed in endothelial cells, its expression in several breast and colon 
epithelial cancer cell lines support the idea that Tie1 may play a role in cell activation. 
 
The Role of Hemodynamic Shear Stress on the Endothelium 
 
Biomechanical Forces Exerted by Blood Flow on the Vessel Wall 
 
The Endothelium 
The endothelial monolayer exists as a dynamic interface between the circulating 
hematologic components and the vascular wall. Endothelial cells experience a wall shear 
stress associated with the viscous flow of blood, and studies have shown vascular  
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Figure 1.1.6 Signaling pathways of Tie1 and Tie2. Summary of the effect of 
angiopoietins on Tie1 and Tie2 signaling. Numerous functions have been implicated 
downstream of Ang-Tie signaling. Modified from Loughna (2001). 
 
Angiopoietin, Ang; endothelial cells, EC; extracellular matrix, ECM. 
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endothelial biology to be influenced by shear stress (Dewey et al., 1981; Levesque & 
Nerem, 1985; Ives et al., 1986; Levesque et al., 1986). Disruption to the integrity and 
permeability of this monolayer allows the localized influx of low-density lipoproteins and 
other inflammatory molecules into the sub-endothelium (White & Frangos, 2007). 
Vascular endothelial cells reside in a hemodynamically imposed mechanical 
environment, so it is important to recognize the details of the dynamics of blood flow in 
the vascular system. 
 
Fluid Mechanics 
Due to the nature of its viscosity and the pressures required for its delivery to the 
extremities, as blood flows through a vessel it exerts a physical force on the vessel wall. 
This force can be resolved into primary vectors in three dimensions (Figure 1.2.1). First, 
a force in the longitudinal direction parallel to the vessel wall and to the direction of 
blood flow is defined as shear stress. This represents the frictional force that blood flow 
exerts on the endothelial surface. Second, a circumferential force tangential to the 
circumference of the vessel is termed cyclic stretch. This represents the effect of 
hemostatic pressure on distension of the vessel wall, with effects on endothelial and 
smooth muscle cells and extracellular matrix components. Third, hydrostatic pressure 
also exerts a radial force perpendicular to the vessel wall, compressing the endothelium 
and vessel wall components. This dissertation focuses on the effect of wall shear stress on 
the endothelium. 
It is important to distinguish fluid shear stress from fluid shear rate, two physical 
concepts that are characteristics of the local flow dynamics. Fluid shear rate relates to the  
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Figure 1.2.1 3-dimension vectorial representation of hemodynamic forces on the wall 
of a blood vessel. 
 
 23 
velocity of fluid particles with respect to its perpendicular distance from the endothelial 
surface. Fluid shear stress is the force in the direction of flow exerted by the fluid 
components as they pass adjacent to the endothelial cell. Fluid shear stress can be defined 
as a function of fluid shear rate.  
In regions where blood flow is unidirectional without recirculating flow patterns, the 
time averaged mean shear stress value is positive (i.e. blood flows forward). Shear stress 
values in humans vary from 1-6 dynes/cm2 in the venous system and 10-70 dynes/cm2 in 
the arterial trees  (Figure 1.2.2) (Malek et al., 1999).  
 
1 Dyne = 1 x 10-5 Newtons 
 
Following Newton’s 2nd Law of Motion, 
 
Force = Mass x Acceleration 
 
To qualitatively describe the value of force, 1 Newton is the force required to move 1 
kilogram of mass at an acceleration of 1 meter/second2 (m/s2). Hence, 1 Dyne is the force 
required to move 1 x 10-5 kilograms of fluid mass (blood) at an acceleration of 1 m/s2. 
 
Calculation of shear stress (τω) in vivo can be performed utilizing Poiseuille’s Law 
(Westerhof et al., 2005): 
 
τω = (4 ⋅ µ  ⋅ Q) / (r
3 ⋅ π) 
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Figure 1.2.2 Illustration of typical shear stress magnitudes in human vasculature. 
Adapted from Papaioannou (2006) and Cheng (2007). 
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where µ = blood viscosity, Q = blood flow rate, r = internal vessel radius and π = the 
mathematics constant (3.14159265). The following assumptions have to be made in order 
to apply the law for the estimation of shear stress:  
(i) blood is considered a Newtonian fluid*,  
(ii) the cross-sectional area of the vessel is cylindrical,  
(iii) the vessel is straight with inelastic walls,  
(iv) blood flow is steady and laminar, and 
(v) there are no slip boundary conditions (i.e. velocity at the wall is zero).  
 
(*Definition of Newtonian fluid – a fluid in which the shear stress is directly proportional 
in a linear fashion to the velocity gradient in the direction normal to the plane of shear, 
and this relation is guarded by a constant, the fluid viscosity. The viscosity of the fluid is 
only dependent on temperature, pressure and chemical composition. In vivo, blood 
viscosity is directly related to hematocrit.) 
Qualitatively, Poiseuille’s Law describes the change in pressure (force) with radial 
distance (Figure 1.2.3). The equation assumes that the velocity vector profile of blood 
flow is parabolic such that fluid next to the wall essentially has zero forward force. This 
relation highlights the fact that relatively small decreases in vessel diameter at a constant 
flow rate can markedly increase shear stress at the endothelial surface. Clearly, blood 
vessels do not remain perfectly cylindrical and blood flow velocity is not always 
parabolic, nevertheless, Poiseuille’s Law can be used to relate pressure drop to shear 
stress. 
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Figure 1.2.3 Hemodynamic forces in the vasculature. Major hemodynamic forces 
include flow-derived shear stress (SS), radial pressure (P) and tension-derived tensile 
stress (TS, stretch).  
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Types of Physiological Flow Profiles 
Movement of fluid has two basic components, a directional scalar and a magnitude 
vector. Flow patterns in vivo have been broadly separated into laminar and non-laminar 
flow. The unidirectional movement of fluid and its component particles comprises 
laminar flow. It is also important to clarify that non-laminar flow (also commonly 
referred to as disturbed flow (Asakura & Karino, 1990; Chiu et al., 1998; Davies et al., 
1999; Gimbrone et al., 2000; Chien, 2003; Li et al., 2005; Chien, 2008)) is a term for a 
group of flow profiles that include recirculatory and turbulent flow (Motomiya & 
Karino, 1984; Fukushima et al., 1988; Peacock, 1990; Davies, 1995; Davies et al., 1999).  
Recirculatory flow is characteristic of vascular branch points (Davies et al., 1999) 
such as the vertebral, celiac, mesenteric and renal artery branches of the aorta, and the 
most studied of which are branches of the aortic arch (Suo et al., 2007) and the carotid 
artery bifurcations (Motomiya & Karino, 1984; Fukushima et al., 1988). Due to the 
pulsatile nature of blood flow, the outer wall of the branching vessel experiences 
bidirectional blood flow with the resultant effect of a low time-averaged shear stress 
(Figure 1.2.4) (Asakura & Karino, 1990).  
The complex profile of turbulent flow is not to be confused with recirculatory flow. 
Turbulence implies characteristics of chaotic flow, encompassing amongst others, two 
distinguishing qualities: (1) an unsteady flow pattern with spinning vortices, 
superimposed with (2) random movement of fluid components (Peacock, 1990; White & 
Frangos, 2007). This highly unique flow profile is found almost exclusively in the aortic 
sinuses. Although, in rare circumstances, it is possible to achieve turbulent flow under 
laminar flow conditions if the Reynold’s number (ratio of fluid velocity to viscosity)  
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Figure 1.2.4 Flow divergence at vessel bifurcations. (A) Illustration of flow profiles at a 
vessel bifurcation. Low shear stress magnitude and oscillatory flow patterns are common 
at the outer wall. (B) Glass model of human carotid sinus visualized by gas bubbles. In 
regions B and C, there is separation of laminar flow creating a region of flow 
recirculation that reattaches to the main flow downstream in region D. Also note absence 
of flow separation on wall of the flow divider. Adapted from Davies (1995) and Ku 
(1985). 
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attains an uncharacteristically high value. However, this is extremely rare and will not be 
discussed further (Peacock, 1990). To date there is not an in vitro flow model that 
reliably mimics the chaotic flow patterns. 
 
Even though flow is laminar, it is still extremely complex in character. Velocity 
profiles are asymmetric due to the complicated geometry of the vasculature with the 
result that wall shear stress is not only temporally variable but also spatially variable. 
There is still a rather large variation in wall shear stress of arterial segments experiencing 
laminar flow. Several in vitro models have been devised and successfully employed to 
study the flow characteristics and endothelial responses to laminar flow. 
 
In vitro Systems of Fluid Shear Stress 
Although it is important to understand the complexity of the in vivo hemodynamic 
environment, the systems that have been developed for use in cell culture studies of 
hemodynamic effects on endothelial biology have been much simpler. The modeling of 
in vivo fluid flow dynamics has been a pursuit of the medical and engineering disciplines 
for over two decades. In general, the systems devised up to now have focused on each 
mechanical force component separately. Thus, there are methods for the investigation of 
flow effects and methods for the study of cyclic stretch. The systems employed for the 
investigation of flow effects are addressed in this dissertation. 
To understand shear stress, we need to address fluid dynamics. We will assume ideal 
conditions of (a) no-slip conditions at the boundary, (b) fluid that is incompressible 
(Newtonian fluid). Fluid can be characterized by its Reynold’s number, Re: 
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Re = (2 ⋅ r ⋅ u) / µ 
 
where r is the radius of the vessel, u is the fluid velocity and µ is the fluid viscosity 
(Peacock, 1990).  
Qualitatively, the Reynold’s number is a dimensionless parameter describing the ratio 
of fluid velocity to its viscosity. When Re<<1 fluid flow is capable of reaching steady 
state (Truskey et al., 2009), however when Re>1 fluid flow conditions tend toward 
turbulence.  
We will first address steady flow conditions as this is most commonly encountered in 
vascular hemodynamics.  
 
1. Cone and Plate Shear Stress apparatus (Figure 1.2.5) (Bussolari et al., 1982) 
The pioneer model was designed by Dewey, Bussolari and Gimbrone in 1982 
(Bussolari et al., 1982). Their cone and plate viscometer system is still widely 
used today. The apparatus utilizes a modified cone and plate viscometer. Rotation 
of the inverted cone drives movement of the fluid in an azimuthal direction over a 
monolayer of endothelial cells cultured on a stationary plate. Given a fluid with 
Reynold’s number, Re<<1, the shear stress can be calculated by the following 
formula: 
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Figure 1.2.5 Geometry of cone and plate shear stress apparatus. (A) Original design of 
apparatus showing sample of apparatus. (B) Geometry of apparatus and variables 
pertinent to the calculation of shear stress. Adapted from Bussolari (1982) and Davies 
(1984). 
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  The azimuthal velocity, υ is: 
 
υ = (ω ⋅ z) / α 
 
where ω is the angular velocity of the rotation, z is the azimuthal height from the 
plate surface and α is the cone angle in radians. 
 
Calculating the rate of change of azimuthal velocity with respect to the distance of 
flow particles from endothelial surface would give us the fluid shear rate: 
 
δυ/δz = δ(ω ⋅ z/α) / δz = ω /α  
  
The fluid shear stress τω can then be calculated, 
 
τω = µ ⋅ (δυ/δz) 
 
or, substituting the formula of fluid shear rate,  
 
τω = µω /α  
 
where, µ is the viscosity of the fluid (~0.0101 poise).   
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The cone and plate apparatus, as utilized in our experiments, has the 
advantage of a well-defined flow field without the interference of pressure 
gradients and it also permits a wider dynamic range of shear stresses. 
Additionally, turbulent flow conditions can also be achieved with fluid of Re>1 in 
this system, or by increasing the cone angle to 1o radians (Bussolari et al., 1982). 
 
2. Parallel Plate Shear Stress model (Figure 1.2.6) 
The parallel plate chambers were first reported from a laboratory at Georgia 
Institute of Technology (Levesque & Nerem, 1985). The key feature of the 
parallel plate system utilizes the generation of a continuous flow loop to deliver a 
predetermined and constant flow rate across a cultured endothelial monolayer in a 
geometrically uniform flow chamber. The cells in the chamber are exposed to a 
specific shear stress condition as defined by the dimensions of the flow chamber 
and the pressure drop across the chamber. Studies have modified this chamber 
with a step system creating a secondary recirculating flow system downstream of 
the step (Figure 1.2.6B). These modified step flow systems offer qualitative 
analyses of molecular responses to recirculating flow. Pulsatile flow and its 
variations have been conducted using the parallel plate flow chamber (Helmlinger 
et al., 1991; Helmlinger et al., 1995). Additionally, parallel plate flow chambers 
have been adapted to fit under microscopes for continuous observation of cellular 
responses during experiments.  
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Figure 1.2.6 Parallel plate flow chamber. (A) Endothelial cells seeded on a tissue 
culture treated chamber are subjected to media flow (red arrow). Media exiting the 
chamber returns to a buffer reservoir that is aerated with air + 5% CO2 mix. A peristaltic 
pump delivers media to the chamber at a controlled flow rate, and the flow can be 
modified with an oscillatory pump to simulate bidirectional flow. The parallel plate 
chamber has the advantage of size and can be built using optically permissive material for 
real-time recording of cellular responses with a microscope. (B) The parallel plate flow 
chamber may be modified with a “step”, creating a zone of disturbed flow immediately 
distal to the obstacle (a-b), a reattachment zone (c), and resumption of laminar flow (d). 
Adapted from Chien (2008). 
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3. Orbital shear stress model 
First reported by Tsao et al in 1995 (Tsao et al., 1995), orbital shear stress is 
applied to confluent cell cultures by using an orbital shaker positioned inside the 
incubator (Asada et al., 2005; Dardik et al., 2005; Kudo et al., 2005). Endothelial 
cells are seeded onto matrix-coated 6-well culture plates. Different fluid velocities 
and shear stresses are found at the center and periphery of the well (Dardik et al., 
2005). These center and periphery regions were observed to have different 
endothelial cell morphology. Studies with selective seeding of endothelial cells at 
different regions of the well revealed differences in replication rate and nitric 
oxide (NO) production (Dardik et al., 2005).  
 
With all systems, temporally and spatially uniform fluid shear stress profiles can be 
achieved (reviewed in (White & Frangos, 2007)). Temporal shear stress gradients are 
defined as changes in shear stress over a small period of time at a defined location. The 
gradient is a function of time and hence directly proportional to the rate of change of 
flow. The value of temporal shear stress gradients is that they can be designed to mimic 
pulsatile flow conditions in vivo. Spatial shear stress gradients are defined as changes in 
shear stress between two predetermined points on the endothelial monolayer. As a point 
of note, spatial shear stress gradients can also be defined as two points on a cell when 
used in atomic force microscopy devices. 
On the other hand, in vitro temporal shear stress gradients may be undesirable 
especially in experiments evaluating rapid response molecules such as PDGF, where 
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changes are observed within 5 minutes (Aromatario et al., 1997; Hu et al., 1998; Sumpio 
et al., 1998; Bao et al., 1999). However, temporal shear stress gradients at the onset of 
fluid flow can be resolved by allowing at least 30 seconds for flow conditions to reach a 
steady state (White & Frangos, 2007).   
 
Types of in vitro Shear Stress Patterns 
A variety of shear stress patterns have been used to replicate in vivo flow, including 
laminar flow, pulsatile laminar flow, step flow, oscillatory flow. Steady state flow 
conditions, simply defined as the application of one flow rate for the duration of the 
experiment, is a common methodology of in vitro shear stress experiments. The steady 
state laminar flow system offers the attractiveness of a one variable simplicity in 
experiments. However, pulsatile laminar flow addresses the cyclic nature of in vivo blood 
flow. The step flow system offers the additional quality of conditioning the cells for a 
period of time before subjecting them to a different shear stress magnitude to assess 
endothelial responses. Chen-Konak et al. used such a system to investigate the effect of 
abrupt shear stress changes on the transcription of Tie1 (Chen-Konak et al., 2003). Last, 
oscillatory shear stress systems have been used as a close representation of recirculatory 
flow at bifurcations and to a lesser degree, an approximation of turbulent flow as seen at 
the aortic sinuses. The accepted methodology of this system involves alternating fluid 
direction at 1 hertz (1 cycle per second) and at the rate of +/- 5 dynes/cm2 (Sorescu et al., 
2003).  
 
 
